Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Finding Study of Ivermectin in the Treatment of COVID-19
IRCT20200408046987N1Phase 3Completed
- Sponsor
- Chistasazan Notash Fartak
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Chistasazan Notash Fartak. Started May 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200408046987N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200408046987N1.